Double blind trial of ritodrine and placebo in twin pregnancy
- PMID: 387068
- DOI: 10.1111/j.1471-0528.1979.tb11270.x
Double blind trial of ritodrine and placebo in twin pregnancy
Abstract
In a double blind trial, 25 patients with twin pregnancy were given 40 mg of ritodrine hydrochloride by mouth daily and 24 similar patients received a placebo. The ritodrine group had no significant prolongation of pregnancy nor increase in birth weight, and a high incidence of side effects occurred.